This contract involves the ongoing supply of consumables and reagents for testing glycosylated hemoglobin (HbA1c), along with the free loan of analyzers for a duration of 8 years. The total expected quantity is 208,000 reported HbA1c results over this period, averaging 26,000 results per year. The c
Contract awarded. Originally published 1 years ago.
This public procurement contract involves providing service activities for medical devices, specifically validation and conducting safety technical inspections, including electrical checks of the specified devices in accordance with Act No. 375/2022 Coll. on in vitro medical devices for equipment ow
This public procurement contract involves providing maintenance services for medical devices, specifically focusing on validation and conducting safety technical inspections, including electrical checks, in accordance with Act No. 375/2022 Coll. on in vitro medical devices for equipment owned by the
This procurement contract involves the supply of materials, accessories, and other consumables necessary for conducting the required reported tests using integrated biochemical and immunochemical analytical systems. Additionally, it includes the provision of free loan of analytical systems, installa
This contract involves the ongoing supply of consumables and reagents for the testing of glycosylated hemoglobin (HbA1c), along with the free loan of analyzers for a duration of 8 years. The total expected quantity is 208,000 reported HbA1c results over this period, averaging 26,000 results per year
Supply non-clinical consumables including forms, labels, and packaging for pathology and primary care services.
Procurement of RSV immunisation vaccine products for adult populations, scheduled for 2028.
Procurement for meningococcal ACWY vaccine supply in 2027 from qualified manufacturers or distributors.
Procurement opportunity for MMR vaccine supply with anticipated delivery timeline of 2027.
